Acetylcysteine Inhalant
FDA Label NDC 55154-5730

35 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Acetylcysteine (NDC 55154-5730). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, clinical pharmacology, indications and usage, contraindications, warnings, general, drug interactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-5730-5

ACETYLCYSTEINE SOLUTION, USP

10% (100 mg/mL)

5 x 4 mL VIALS

10% Bag Label (2bcb9dd3 17f8 439e A395 Aa081c5cc4bf 01)

10% Bag Label (2bcb9dd3 17f8 439e A395 Aa081c5cc4bf 01)

NDC 55154-5731-5

ACETYLCYSTEINE SOLUTION, USP

20% (200 mg/mL)

5 x 4 mL VIALS

20% Bag Label (2bcb9dd3 17f8 439e A395 Aa081c5cc4bf 00)

20% Bag Label (2bcb9dd3 17f8 439e A395 Aa081c5cc4bf 00)

* Please review the disclaimer below.